Quality Assurance at the European Monitoring Centre for Drugs and Drug Addiction Sandrine Sleiman European Conference on Quality in Official Statistics,

Slides:



Advertisements
Similar presentations
TREATMENT DATA INDICATORS IN THE UNODC DATA COLLECTION SYSTEM.
Advertisements

The EMCDDA and the Reitox network: towards quality achievement Sandrine Sleiman, Scientific Committee, Palmela, February 2008.
Quality feedback: Validation of TDI Standard Table submitted in 2005 (2004 data) Sandrine Sleiman, Xavier Poos September 2006.
February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
Overview of the 2011 Work Programme Paul Griffiths Scientific committee meeting, Lisbon, November 2010.
1 Assessment of Cambodia’s Statistics Capacity Prepared by Zia A. Abbasi IMF Multi-sector Statistics Advisor, Cambodia for the International Conference.
The quality framework of European statistics by the ESCB Quality Conference Vienna, 3 June 2014 Aurel Schubert 1) European Central Bank 1) This presentation.
Overview of the 2010 work programme Paul Griffiths, Roland Simon, Rosemary de Sousa Scientific Committee meeting, Lisbon, November 2009.
ECVET WORKSHOP 2 22/23/24 November The European Quality Assurance Reference Framework.
Strenghtening collaboration with Serbia - IPA4 Project expected outcomes Frédéric Denecker, Programme Management Officer Reitox and International Cooperation.
An Introduction to Monitoring and Evaluation for National TB Programs.
Comprehensive M&E Systems
Quality evaluation and improvement for Internal Audit
ARQ part II data management Training pack 2: Monitoring drug abuse for policy and practice.
Drug use, related problems and interventions targeting drug users in prison in the European countries: main issues and challenges for the future Linda.
Standards and Guidelines for Quality Assurance in the European
Information needs for effective drug policy in the programme of the CZ PRES Identifying Europe’s information needs for effective drug policy Lisbon /
The REITOX Experience Lessons learned in developing a network of National Drugs Focal Points and challenges for the future Alan Lodwick, Head of UK National.
Food insecurity: How to monitor a complex problem Pietro Gennari, Director, FAO Statistics Division.
European Monitoring Centre for Drugs and Drug Addiction Margareta Nilson ISAJE, Helsinki, 1 September 2006.
Urban-Nexus – Integrated Urban Management David Ludlow and Michael Buser UWE Sofia November 2011.
The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager 1.
Process of Development of Five Year Strategic Plan for Child Health Development Dr Myint Myint Than Deputy Director (WCHD) Department of Health.
Quality assurance in IVET in Romania Lucian Voinea Mihai Iacob Otilia Apostu 4 th Project Meeting Prague, 21 st -22 nd October 2010.
Municipal Drug Policy Legislation, institutions and programs Assoc. Prof. Hristo Bozov, MD, PhD Deputy-Mayor of Municipality of Varna Chairman of Municipal.
Jennifer Hillebrand, „Rehabilitation of Drug Addicted Persons: Experience of Lithuania and European Countries”, 18 October 2007 Improving drug treatment.
Validation of Non-formal Adult Education courses REACTION No CP LT-GRUNDTVIG-G1.
Community agencies: partners in accession Cooperation with EMCDDA - Polish experience Boguslawa Bukowska, National Bureau for Drug Prevention ,
Security, Democracy & Cities Security, Democracy & Cities Democracy,
8-11-Jul-07 How to increase quality of Principal European Economic Indicators? Roberto Barcellan, Brian Newson, Klaus Wurm Eurostat.
Marina Signore Head of Service “Audit for Quality Istat Assessing Quality through Auditing and Self-Assessment Signore M., Carbini R., D’Orazio M., Brancato.
Assessment on the implementation of the Mediterranean Strategy for Sustainable Development Dr Nicola Cantore Overseas Development Institute,
ESPON Seminar 15 November 2006 in Espoo, Finland Review of the ESPON 2006 and lessons learned for the ESPON 2013 Programme Thiemo W. Eser, ESPON Managing.
Toolkit for Mainstreaming HIV and AIDS in the Education Sector Guidelines for Development Cooperation Agencies.
Paris Project Meeting January 2012 Item – Statistics Objective 5 B. Proia With financial support from Criminal Justice Programme 2008 European Commission.
Regional Policy Major Projects in Cohesion Policy Major Projects Team, Unit G.1 Smart and Sustainable Growth Competence Centre, DG Regional and Urban Policy.
MAP-IT! Review Meeting 5 March Brussels MAP IT Questionnaire INNOVA/ITIDA.
EU Funding opportunities : Rights, Equality and Citizenship Programme Justice Programme Jose Ortega European Commission DG Justice.
United Nations Statistics Division Registry of national Classifications.
Paul Griffiths and Roland Simon Wrap-up presentation What has the EMCDDA learned ?
6 th Regional Statistics Seminar November 1 st, 2013 St. Kitts Marriott, Frigate Bay Beverly Harris 6 th Regional Statistics Seminar November 1 st, 2013.
ELDD Reflection – past, present and future 29th Meeting of the Scientific Committee, 18 Nov 2008.
Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.
Global Toolkit on Treatment Demand Data State of Progress Michael Donmall (Co-ordinator Joint Project) N ational D rug E vidence C entre.
Linda Montanari, Buenos Aires, October 2003 CICAD/OAS, Demand Reduction Experts Group Meeting The Information System on Treatment Demand in EU EMCDDA.
EMCDDA Work Programme Key Issue 1: Key Indicators 30th Meeting of Scientific Committee J Vicente (together with D Olszewski, D Klempova, L Montanari,
Project Management Learning Program 7-18 May 2012, Mekong Institute, Khon Kaen, Thailand Writing Project Report Multi-Purpose Reporting.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Overview of EMCDDA’s 2009 Scientific Work Programme Paul Griffiths, Roland Simon - REITOX Meeting, Lisbon, November 2007.
Kathy Corbiere Service Delivery and Performance Commission
BEST PRACTICE PORTAL BEST PRACTICE PORTAL project presentation to the Scientific Committee Ferri et al Lisbon, 16th July 2010.
EVALUATION OF THE SEE SARMa Project. Content Project management structure Internal evaluation External evaluation Evaluation report.
Monitoring and reporting on the drug phenomenon in Europe EMCDDA mandate and activities Wolfgang Götz, Scientific Committee, Palmela, 14 February 2008.
Data quality and feedback from the assessment on 2000 and 2001 TDI data 1 EMCDDA, TDI meeting, 23/24 June 2003 Luis Royuela.
Developing National Capability for Integrated Border Management (IBM) in Lebanon Project Funded by the European Union Implemented by the International.
European network for Health Technology Assessment | JA | EUnetHTA European network for Health Technology Assessment THL Info.
1 Recent developments in quality related matters in the ESS High level seminar for Eastern Europe, Caucasus and Central Asia countries Claudia Junker,
Evaluation of Action Plan Turkish Monitoring Center for Drugs and Drug Addiction TUBIM.
Priorities in building up statistics in pre-accession countries Barbara Domaszewicz Agriculture Department, Central Statistical Office of Poland Workshop.
Project: EaP countries cooperation for promoting quality assurance in higher education Maria Stratan European Institute for Political Studies of Moldova.
21 June 2011 High level seminar for EECCA on “Quality matters in statistics” High level seminar for EECCA on “Quality matters in statistics” The Code of.
GUIDELINES Evaluation of National Rural Networks
Evaluation of the Hungarian National Strategy on Drugs
Global Mechanisms for Reporting of Treatment Data
Quality assurance : state of progress
…and still actual for a post-2010 strategy!
Assessment of Quality in Statistics GLOBAL ASSESSMENTS, PEER REVIEWS AND SECTOR REVIEWS IN THE ENLARGEMENT AND ENP COUNTRIES Mirela Kadic, Project Manager.
The Estonian experience with ex-ante evaluation – set-up and progress
Data collection and validation support for the management of the ESF
Skopje, 21 November 2017, General Population Survey results– launch
Presentation transcript:

Quality Assurance at the European Monitoring Centre for Drugs and Drug Addiction Sandrine Sleiman European Conference on Quality in Official Statistics, Rome 8-11 July 2008

Contents Scope of EMCDDA activities Quality assurance: operating framework Challenges and results

Who we are A decentralised EU agency Formally established in 1993 Based in Lisbon, Portugal (operating since 1995) The hub of drug-related information in the EU

Guiding principles and priorities: Principles Scientific excellence Partnership Good governance and efficiency Priorities Consolidating monitoring and reporting activities Enhancing data analysis Communicating more effectively

Collecting and analysing existing data Areas: Epidemiology — drug situation, monitoring new trends, five key indicators Interventions — health, social and criminal justice responses, best practice in demand and supply reduction Legislation — national and Community strategies and policies Policy — political and institutional framework, coordination

Five Key indicators Drug use in the general population (students and young adults): prevalence and patterns of drug use in the general population Drug users accessing treatment (TDI) Drug related infectious diseases (HIV, HCV, HBV) Drug related deaths and mortality of drug users Problem drug use: prevalence and patterns of problem drug use Requires commitment from MS to invest in data collection on a routine basis

Type of data collected Annual registry and epidemiological data Descriptive and qualitative data (non-annual) Data from research studies Institutional data Database cases Coverage and availability of prevention, treatment and harm reduction Statistics from law enforcement sources

Collecting and analysing existing data Reitox national focal points (NFPs), national experts Annual reporting to EMCDDA (national reports, standard tables, questionnaires) Expert groups for developing indicators (nominated by NFPs) Ad hoc working groups

Reporting system: standard templates National reports and selected issues (based on detailed guidelines) Standard Tables (ST) for quantitative information Sturctured Questionnaires (SQ) for qualitative information supplementing ST and NR

Quality Management at the EMCDDA Data collection instruments Quality overviews Quality Control by Scientific Units Quality assurance at EMCDDA level Data Validation Data collection instruments, protocols and guidelines National Focal Points & National data providers Data submission in FONTE, including quality control at national level National data providers Quality Assurance by QA team

Main quality related outputs & reports l Annual Quality reports Implementation Needs Profiles on the 5 key indicators EU experts groups ad-hoc documents Regular reporting to EC on implementation of 5 KI and on quality of reporting

Annual Quality reports

Criteria for National reports Completeness: the report contains all the necessary and existent information in order to provide an overview of the situation Insight: the report includes complete and significant information, giving an interpretation to the reported information, according to social and political contexts. Reliability: the extent to which the information in the report allows comparisons (between different time periods). Usefulness: information oriented to the targets; acceptable and pertinent to the report objectives; no redundant information is presented. Internal consistency: the extent to have coherent information in the report or to describe the reasons for a lack of internal consistency.

Criteria for data checking in STs CNDA: Not clear whether all data in the ST are new or not CQUA: Quantitative information needed clarification CQUAL: Qualitative information needed clarification CREF: References needed clarification DNR: Discrepancy between NR and ST MDA: Quantitative information missing MME: Methodological information missing MRE: References missing OTH: Others

Criteria for SQ Level of details Insufficient, sufficient, good Conciseness Insufficient, sufficient, good Discrepencies with NR Yes - No General comment Any other important feedback

Implementation Needs Profiles Concerns 5 key epidemiological indicators Focuses on activities related to indicators and partially on content Is a general analysis, helps to identify problematic areas, status quo or improvement in data collection

Criteria used Most recent data Reference Description Weaknesses Activities implemented or ongoing/planned Actions needed

Quality assurance: work in progress Quality Assurance… is mentioned as a priority in the EU action plan is mentioned in the external evaluation report is part of the EMCDDA’s 3-year work programme Quality documents should be … considered as real tools for the EMCDDA and the REITOX network (as well as for external actors) aimed at scientific excellence and not administrative purposes an overview of strengths and weaknesses of data or collection processes …

Quality assurance: work in progress Production of 5 KI methodological packages Definition of precise assessment criteria for 5 KI based on : minimum implementation standards specific to each indicator sensitive to national contexts somewhere between pragmatism and perfection Redefinition of templates and guidelines with adaptation of quality criteria

Quality assurance : work in progress Understand needs and capacity to deliver from the Reitox network Priorities for value delivery: revision of reporting guidelines Promise what can be delivered Change capability to match promise Deliveries matching standards and priorities Change capability to match future needs: - Quality feedbacks - Capacity development activities

Case study: national reports Success Recommendations for improvement are generally applied as regards adherence to guidelines: -Document layout -References to standard tables and structured questionnaires -Sources and use of Harvard for bibliography -Methodological information is more precise -Efforts in writing the National report

Case study: national reports Gaps Deadlines missed Conciseness Lack of insight on trends and interpretation of results In some countries, it is still too early to have information on trends Work on quality assurance depends on external factors, such as Member States’ involvement in quality issues

THANK YOU FOR YOUR ATTENTION